Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R41/R42 Clinical Trial Optional)

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) intends to publish a Notice of Funding Opportunity (NOFO) that is a re-issue of PAR-22-103 (entitled �Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage [UT1/UT2 Clinical Trial Optional]�). The re-issued NOFO will continue to solicit Small Business Technology Transfer (STTR) applications that propose the development of therapeutic agents for the treatment of...